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Objective: Fear of cancer recurrence (FCR) is a significant concern for family caregivers
of cancer survivors and is associated with many adverse outcomes, including increased
emotional distress and poorer quality of life. Although several theoretical models have
been proposed to account for FCR in cancer survivors, their applicability to caregivers is
unknown. The aim of this review was to identify clinical, demographic and psychological
factors that are associated with, and predict, FCR in caregivers of cancer survivors.
Method: AMED, CINAHL, Medline, PsycINFO, and Scopus were systematically
searched for relevant studies reporting quantitative data on factors associated with
FCR or similar constructs (e.g., worry or anxiety about cancer recurrence) in family
caregivers of adult cancer survivors. Included studies were assessed for methodological
quality using a standardized checklist adapted from the Agency for Healthcare Research
and Quality.
Results: Sixteen studies, half of which were cross-sectional, were included and
summarized narratively. Non-modifiable factors, including age (n = 6) and treatment
modality (n = 4), were found to be associated with increased FCR. Significant positive
associations were also reported between illness perceptions and FCR (n = 3). However,
there was heterogeneity across included studies with regards to factors examined and
most were conducted in the USA. There were also several methodological limitations to
the included studies.
Conclusions: Research examining FCR in caregivers of cancer survivors has
predominantly focused on demographic and clinical factors. Given the paucity of
research exploring the psychological mechanisms underpinning FCR, future research
should investigate theoretical underpinnings of FCR in caregivers of cancer survivors to
support the development of psychological interventions for this population.
Systematic Review Registration: PROSPERO, identifier [CRD42019119729].
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INTRODUCTION
Although improvements in cancer care have led to earlier
diagnosis and more effective, targeted medical treatment (Arnold
et al., 2019), family caregivers of survivors continue to experience
adverse effects of the illness, both physically and psychologically
(Pitceathly and Maguire, 2003; Kurtz et al., 2004; Girgis and
Lambert, 2009). Specifically, cancer caregiving responsibilities
can result in issues such as pain, fatigue, financial difficulties
and social isolation (Girgis and Lambert, 2009; Stenberg et al.,
2010). One of the most distressing concerns for survivors and
their families is fear of cancer recurrence (FCR) (Simard et al.,
2010), defined as “fear, worry, or concern about cancer returning
or progressing” (Lebel et al., 2017). Prevalence of FCR is high
in family caregivers (Yeo et al., 2004) and can be higher than
for the cancer patients (Longacre et al., 2012; Gold et al.,
2016). Managing worries about cancer returning is a commonly-
reported unmet need for caregivers (Girgis et al., 2013; Turner
et al., 2013; Balfe et al., 2016), which is associated with elevated
emotional distress (Longacre et al., 2012) and poorer quality of
life (QoL) (Simard et al., 2013).
Although psychological interventions for FCR have been
widely researched for cancer survivors (Simard et al., 2013;
Maheu and Galica, 2018), there is currently little evidence to
support the utility of specific psychological interventions for
family caregivers experiencing FCR (Simonelli et al., 2017).
To develop more effective interventions for this patient group,
we must first understand the psychological processes that
underpin and maintain FCR in caregivers of cancer survivors.
Much of what we know about these processes is derived from
research investigating FCR in patients. Many of the theoretical
frameworks proposed to account for FCR in cancer survivors
consist of similar components, including internal (e.g., physical
symptoms, treatment side effects) and external (e.g., clinical
follow-up) cues that trigger a cognitive response associated with
FCR (Simonelli et al., 2017). Following an appraisal of such cues,
a variety of coping responses, some less helpful than others, are
implemented which are influenced by the social environment and
other contextual factors (Lee-Jones et al., 1997; Simonelli et al.,
2017). Such coping responses may include avoidance, limited
future planning, symptom checking and misinterpretation of
symptoms, and reassurance seeking from health professionals
and family members, which in the longer term can increase FCR
(Lee-Jones et al., 1997).
Similar to cancer survivors, caregivers often engage in
unhelpful coping behaviors such as avoidance of cancer-
related discussions, reluctance to make plans for the future
and reassurance seeking (Lambert et al., 2013; LeSeure
and Chongkham-ang, 2015). Furthermore, although caregivers
do not experience internal cancer-related cues (e.g. cancer
symptoms or delayed treatment effects), the cancer journey is
experienced by the family as a whole (Kayser et al., 2007).
Therefore, caregivers are often aware of survivors’ physical
experiences of cancer diagnosis and treatment, through helping
patients to manage physical symptoms such as treatment side
effects (LeSeure and Chongkham-ang, 2015). Caregivers are
exposed to many external cues and situations which may trigger
FCR, including cancer-related conversations, media references
to cancer, appointments with health professionals and survivors’
follow-up appointments and feeling unwell themselves (Simard
and Savard, 2009).
Although many components of the FCR models will be
applicable to understanding FCR experienced by caregivers,
some may not be relevant and there may be other factors which
are only relevant to caregivers of cancer survivors. To date,
only two reviews have examined FCR in caregivers (Simard
et al., 2013; Maheu and Galica, 2018). Maheu and Galica
briefly summarized literature regarding factors associated with
FCR in caregivers, but did not take a systematic approach
to identify or analyse data. Simard and colleagues conducted
a systematic review of quantitative studies examining FCR in
adult cancer survivors, within which they briefly summarized
the results of nine studies, published prior to 2011. Collectively,
the two previous reviews indicate that non-modifiable factors
such as caregiver age and gender, and treatment type, may be
associated with caregiver FCR. However, a systematic synthesis
of contemporaneous studies examining correlates and predictors
of caregivers’ FCR does not exist. This systematic review aims
to address this gap by critically appraising and synthesize the
findings of quantitative studies investigating any demographic,
clinical and psychosocial correlate or predictor of FCR in adult
family caregivers of adult cancer survivors.
MATERIALS AND METHODS
Review Conduct and Reporting
Review conduct and reporting adhered to recommendations
by Centre for Reviews Dissemination (2009) and Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidance (Moher et al., 2009). The protocol
was registered on the international prospective register of
systematic reviews, Prospero, in January 2019 (reg. number
CRD42019119729) and can be accessed at https://www.crd.york.
ac.uk/PROSPERO.
Search Strategy
AMED, CINAHL, Medline, PsycINFO, and Scopus were
systematically searched for published literature using the
following search terms: partner (partner∗, couple∗, spous∗,
dyad∗, carer, caregiver, care-giver, care giver, caregiv∗, husban∗,
wife or wives) and (fear∗ or worr∗ or anxiet∗ or concer∗ or afraid)
and (recur∗ or relaps∗ or reoccur∗ or return∗ or progress∗) and
(cancer∗ or tumor∗ or tumor∗). There were no restrictions placed
on publication date. Searches were repeated in March 2020 to
identify any new publications relevant to the review question.
Inclusion and Exclusion Criteria
To be included in the review, studies had to report quantitative
data on factors associated with FCR or similar constructs (e.g.,
worry or anxiety about cancer recurrence) in adult family
caregivers (partners, family members, and close friends) of adult
cancer survivors (both aged ≥18 years). Patients were classed as
cancer survivors if they had received a diagnosis of cancer and
had not been diagnosed with a secondary cancer. Articles had
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to be published in English in a peer-reviewed journal. Studies
were excluded if cancer patients had not yet received treatment,
in order to ensure findings were deemed to be taken from a
survivorship phase. Studies which did not report data separately
for cancer survivors were also excluded (e.g., studies reporting
data from survivors and patients with metastatic disease). All
case studies, commentaries, conference abstracts, dissertations,
editorials, qualitative studies, and review articles were excluded.
Screening and Selection
Two reviewers (LOR and AW) independently assessed the titles
and abstracts of potentially relevant papers. The reviewers then
independently reviewed the full-text papers against the inclusion
and exclusion criteria. Papers which did not meet the inclusion
criteria were removed. Discrepancies (n = 3) were discussed
with the wider research team (MGC, PF, SC) until a negotiated
conclusion was reached.
Data Extraction
For each study, relevant demographic, methodological and
summary data were extracted using a standardized data
extraction form by LOR and independently checked for accuracy
by AW. Uncertainty (n = 1) was resolved through discussion
with the wider research team. Authors were contacted if data
were unclear or had not been reported within the paper.
The following information was extracted: (i) author, (ii) year
of publication, (iii) study design, (iv) clinical and treatment
characteristics of the survivor (diagnosis, stage, time since
diagnosis and treatment type), (v) caregiver demographics
(age, gender, ethnicity, and relationship length), and (vi) main
findings, including correlates and predictors of FCR. Where
studies reported multiple analyses, only data from the most
complex relevant multivariate analyses were extracted. This is
because multivariate analyses that eliminate potential sources
of confounding through statistical control of multiple potential
covariates are considered stronger tests of association than
univariate analyses. Studies that reported data from the same
larger database, but focused analyses on different outcomes
were interpreted and referred to as separate studies, with their
linked status noted. Correlates and predictors were grouped
under the following headings: (i) demographic factors (including
age, gender and ethnicity); (ii) clinical factors (treatment,
cancer stage, co-morbidities and medical follow-up); and (iii)
psychosocial factors (emotional distress, interpersonal factors
(including FCR in patients), stress and coping, quality of
life and psychological beliefs). Data were analyzed narratively;
heterogeneity in study findings precluded meta-analysis.
Risk of Bias
Studies were assessed for risk of bias using a quality appraisal
tool adapted from the Agency for Healthcare Research and
Quality (Williams et al., 2010), which assesses risk of bias in
studies across various domains relevant to research with physical
health populations. This tool considers risk of bias across key
methodological areas, such as sample selection, size, description,
handling of missing data and analysis (Taylor et al., 2015),
thus allowing for comparison of studies across domains. Two
reviewers (LOR and AW) separately assessed risk of bias in
the included studies. Uncertainty (n = 4) was resolved through
discussion with the wider research team (MGC, PF, SC). In
line with Centre for Reviews Dissemination (2009) guidance,
studies were not excluded based on outcome of the risk of
bias assessment.
RESULTS
The search strategy identified 1,729 potentially relevant records.
After exclusion of duplicates and screening of titles and abstracts,
40 potentially eligible articles remained. After reviewing their
full-text, eight articles, reporting seven studies, were identified
for inclusion for review. Nine studies were identified during the
updated search, resulting in the inclusion of 19 articles, reporting
16 studies1. The process of identification of papers to inclusion
for review is summarized in Figure 1. Demographic, clinical and
psychosocial factors examined by each study are summarized in
Table 1.
Study Characteristics
The main characteristics of the studies are shown in Table 2.
Nine studies, reported in 12 articles, were conducted in the
USA (Mellon and Northouse, 2001; Mellon et al., 2006, 2007;
Kim et al., 2012; Boehmer et al., 2016; Janz et al., 2016; Cohee
et al., 2017; Soriano et al., 2018a,b, 2019; Perndorfer et al., 2019;
Wu et al., 2019). The remainder were conducted in Taiwan
(Chien et al., 2018), UK (Hodges et al., 2009; Dempster et al.,
2011; Graham et al., 2016), Ireland (Maguire et al., 2017), The
Netherlands (van deWal et al., 2017) and China (Xu et al., 2019).
Studies used a convenience or purposive sampling strategy and
were either cross-sectional (Mellon and Northouse, 2001; Mellon
et al., 2006, 2007; Dempster et al., 2011; Kim et al., 2012; Boehmer
et al., 2016; Janz et al., 2016; Cohee et al., 2017; Maguire et al.,
2017; van deWal et al., 2017; Soriano et al., 2018a) or longitudinal
surveys (Hodges et al., 2009; Graham et al., 2016; Chien et al.,
2018; Soriano et al., 2018a,b, 2019; Perndorfer et al., 2019; Wu
et al., 2019; Xu et al., 2019). Seven studies recruited patients with
breast cancer, four with head and neck cancer, three with prostate
cancer, and two with mixed cancer diagnoses. The shortest time
since diagnosis or treatment was 90 days (Wu et al., 2019), whilst
the longest time was 7.3 years (SD 3.6) (Boehmer et al., 2016).
Out of the 16 studies, nine focused on partners (Janz et al.,
2016; Cohee et al., 2017; van de Wal et al., 2017; Chien et al.,
2018; Soriano et al., 2018a,b, 2019; Perndorfer et al., 2019;
Wu et al., 2019; Xu et al., 2019), whilst seven studies reported
data on caregivers, including other family members and friends.
Caregivers were predominantly White, female, and middle-aged.
Education level varied across studies, with college or above
1The samples of 26, 27, 28, 38, and 39 were drawn from a larger database (SEER).
Thirty-eight and 39 used the same sample and therefore will be considered as
one study. Twenty-six−28 studied non-overlapping samples and therefore will be
interpreted and referred to as separate studies. Similarly, samples of 29 and 30 were
drawn from a larger study (OPA, UK) but will be interpreted as separate studies as
they used non-overlapping samples. Thirty-one, 35, and 36 were based on data
from the MDCSS database and used the same sample, therefore will be considered
as one study.
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FIGURE 1 | Flowchart of literature search (based on PRISMA guidelines; Moher et al., 2009).
tending to be the most reported education level. Relationship
length varied, with the longest mean length of relationship
between caregiver and survivor being 43.0 years (range 8–57
years) (van de Wal et al., 2017) and the shortest being 24.40 years
(SD 13.8) (Soriano et al., 2018a).
Results of Assessment of Risk of Bias
The results of the assessment of risk of bias are outlined in
Table 3, and indicate that most domains, including unbiased
selection of cohort, validated measures of outcome and
dependent variables, and appropriate analyses rated highly.
Several limitations were identified in relation to study design,
assessment of FCR and justification of sample sizes. Only five
studies reported a sample size calculation (Mellon et al., 2006;
Hodges et al., 2009; Kim et al., 2012; Maguire et al., 2017; van
de Wal et al., 2017). Out of the 16 studies, only four studies
followed caregivers up for an adequate period (defined as at
least 12 weeks). However, half of the studies included for review
were cross-sectional therefore could not be assessed against this
criterion. Most studies provided adequate descriptions of the
study cohort, but three studies provide limited demographic data
(Dempster et al., 2011; Graham et al., 2016; Xu et al., 2019).
Most used validated methods for assessing predictor variables;
however, in one study (Soriano et al., 2018b), it was not clear if the
measures used had been validated. Most studies used validated
measures of assessing FCR; however, in four studies (Kim et al.,
2012; Janz et al., 2016; Wu et al., 2019; Xu et al., 2019), it was
unclear if adapted questionnaires had been validated. In one
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TABLE 1 | Measures of demographic, clinical, and psychosocial factors.
Correlate or predictor
variables




Demographic (n = 12 studies reported in 13 articles)
Age sig. (29, 32, 34, 39, 42, 43) n.s.
(26, 27, 28, 30, 38, 40, 41)
6
Gender sig. (42) n.s. (32, 40, 41) 1
Ethnicity sig. (28) n.s. (27, 32) 1
Education sig. (27) n.s. (26, 28, 32, 38, 41,
43)
1
Clinical (n = 14)
Treatment Time since diagnosis sig. (26, 42) n.s. (27, 29, 32, 39,
40, 43)
2
Treatment type sig. (26, 28, 35, 42) n.s. (32, 38,
43)
4
Medical follow-up sig. (36, 37) 2
Cancer Stage Cancer stage n.s. (26, 28, 26, 32, 38-42) 0
Cancer severity sig. (29) 1
Comorbidities Comorbidities sig. (26, 28) n.s. (32, 39, 40) 2
Survivor physical health sig. (29) 1
Psychosocial (n = 15 studies reported in 18 articles)
Emotional distress Anxiety sig. (29, 34, 36) 3
Emotional distress sig. (41) 1
Interpersonal factors Survivor/caregiver FCR sig. (26, 29, 30, 32, 33, 34, 36,
41, 43) n.s. (35, 38)
8 studies reported in 9 articles
Relationship quality sig. (34) n.s. (38) 1
Social support sig. (26) n.s. (30, 31, 32, 42) 1
Loneliness sig. (42) 1
Communication sig. (27, 33, 34, 37, 44) 4 studies reported in 5 articles
Spousal negative affect sig. (34) 1
Stress and coping Stress sig. (30, 31, 32, 42) 2 studies reported in 4 articles
Coping strategies sig. (39, 40) 2
Quality of life sig. (29, 30, 31, 42, 43) 4 studies reported in 5 articles
Psychological beliefs Meaning of illness sig. (30, 31, 32) 1 study reported in 3 articles
Illness perceptions sig. (39, 40, 44) 3
sig, significant results; n.s., Non-significant results.
study, it was unclear if confounding demographic variables were
controlled for in analyses (Chien et al., 2018).
Demographic Factors
There were significant associations between age and FCR.
Twelve studies, reported in 13 articles, examined the relationship
between age and FCR. Of these, one study found a weak
negative association between age and FCR (r = −0.17) (Kim
et al., 2012) whilst five studies reported a significant association
which remained significant when other clinical and demographic
variables were controlled (Mellon et al., 2007; Dempster et al.,
2011; Maguire et al., 2017; van de Wal et al., 2017; Soriano et al.,
2018a). However, no details regarding cancer stage and treatment
type were reported in one study (Dempster et al., 2011). Four
studies assessed the relationship between gender and FCR, one
of which found a significant weak association between gender
and FCR, with female carers reporting higher FCR than male
carers (Maguire et al., 2017). Of the three studies that assessed
the relationship between ethnicity and FCR, only one found
a significant relationship, reporting that Latino partners were
significantly more likely to worry than White partners, whilst
Black partners were less likely to report worry (Janz et al., 2016).
However, as this study used an adapted FCR measure, it is
not clear if this has been validated. Seven studies assessed the
relationship between education and FCR. Of these, one study
found a very weak negative association between education and
FCR (r = −0.16) (Cohee et al., 2017), however as there is no




There was limited support for significant associations between
time since diagnosis and FCR. Two out of the eight studies that
assessed the relationship between time since diagnosis and FCR
found that those caring for more recently diagnosed survivors









































TABLE 2 | Study characteristics.
Caregiver Survivor













Boehmer et al. (2016), USA Cross-sectional Ha 43
Mb 124
M = 62.4 (8.0)
































M + (Re): 9 (7.3)
R: 80 (64.5)
H: 88 (71.0)
Chien et al. (2018), Taiwan Longitudinal
(T4 = 24 weeks)
T4 =46 M = 62.0 (7.8) Female: 48 (100.0)
Male: 0 (0.0)






Cohee et al. (2017), USA Cross-sectional 222 M = 47.98 (7.2) Not reported Partner: 222
(100.0)
Breast Not reported 5.83 years (1.51) Not reported





Esophageal Not reported Mdn = 46 months
(19–81)
Not reported
Graham et al. (2016), UK Longitudinal
(T2 = 12 months)





Esophageal Not reported M = 4 years (2–7) Not reported
Hodges et al. (2009), UK Longitudinal
(T2 = 6 months)







Head and neck 1-2 = 27 (60)
3-4 = 16 (35.6)
5 = 2 (4.4)
Not reported Not reported





Not reported Partner: 510
(100.0)
Breast 0 :125 (24.5)
I-II: 388 (66.3)
III: 46 (9.0)

















2.2 years (0.40) Not reported







Head and neck I-II: 81 (54.4)
III-IV: 68 (45.6)



























































































TABLE 2 | Continued
Caregiver Survivor














(2001), Mellon et al. (2006,
2007), USA



























Soriano et al. (2018a), USA
Study (1)






C and/or H: 15
(33)




72 M = 59.49 (10.34) Male:70 (97)
Female: 2 (3)








Soriano et al. (2019), USA Longitudinal
(21-day diary)
57 M = 60 (10) Male: 55 (96)
Female: 2 (4)





12.2 months (1.9) C:17 (30)
R: 41 (72)
H: 48 (84)
van de Wal et al. (2017), The
Netherlands
Cross-sectional 168 Mdn = 67.4
(40-86)
Not reported Partner: 168
(100.0)
Prostate Not reported Mdn = 7.5 years
(0.9-20.0)
S:126 (75)
S + R: 41 (25)
Wu et al. (2019), USA Longitudinal
(T1 = 6 months;
T2 = 12 months)
62 M = 64.3 (8.4) Not reported Partner: 62 (100.0) Prostate Not reported 89.8 days (95.0) R: 36 (52.2)
S: 18 (26.1)
B: 7 (10.1)
R + B: 3 (4.3)
S + R: 1 (1.4)
WW: 1 (1.4)
Missing: 3 (4.3)
Xu et al. (2019), China Longitudinal (10
days)






a Cancer survivors who identify as heterosexual women (HSW).
b Cancer survivors who identify as sexual minority women (SMW).
c Partners surveyed at Time 2 only.
d Mixed cohort = breast, prostate, colorectal, lung, ovarian, kidney, uterine, bladder, non-Hodgkin’s lymphoma, skin melanoma.
e Mixed cohort = Breast, prostate, colon-rectal, uterine.
Treatment modality: S, Surgery; C, Chemotherapy; R, Radiotherapy; L, Lumpectomy; M, Mastectomy; M + Re, Mastectomy and Reconstruction; (U)M, Unilateral Mastectomy; (B)M, Bilateral Mastectomy; H, Hormonal therapy; B,
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reported higher FCR (Boehmer et al., 2016; Maguire et al.,
2017) which remained significant when controlling for other
demographic and clinical factors (Maguire et al., 2017). Of these
studies, one study met all of the quality assessment criteria
(Maguire et al., 2017), however sample size calculation was not
reported in Boehmer et al. (2016)’s study, which may indicate
issues regarding statistical power and potential for Type I errors.
Data demonstrated mixed support for significant associations
between type of medical treatment and FCR. Seven studies
assessed the relationship between type of treatment and FCR.
Of these, one study reported a very weak positive association
between chemotherapy and FCR (r = 0.14) (Maguire et al.,
2017), whilst three studies reported significant results which
remained significant after controlling for other demographic and
clinical variables (Boehmer et al., 2016; Janz et al., 2016; Maguire
et al., 2017; Wu et al., 2019). Those caring for survivors who
had received anti-estrogen therapy (Boehmer et al., 2016) or
chemotherapy (Janz et al., 2016; Maguire et al., 2017) reported
higher FCR. Two studies found that those caring for survivors
who had undergonemajor surgery were more likely to have lower
FCR (Maguire et al., 2017; Wu et al., 2019). This finding was
significant when controlling for other demographic and clinical
variables at 6 months post-treatment, but not at 12-months (Wu
et al., 2019).
Cancer Stage
Seven studies explored the relationship between cancer stage and
FCR, none of which found a significant association (Mellon et al.,
2007; Hodges et al., 2009; Kim et al., 2012; Boehmer et al., 2016;
Janz et al., 2016; Maguire et al., 2017; Chien et al., 2018). One
study assessed the relationship between cancer severity and FCR,
and found a significant positive association when controlling
for other demographic and clinical variables (Kim et al., 2012).
However, as this study used an adapted FCR measure, its
psychometric properties are unknown.
Comorbidities
There was limited support for associations between
comorbidities and FCR. Of the five studies that assessed
the relationship between comorbidities and FCR, two found
that greater number of comorbidities resulted in higher FCR
when controlling for other variables, specifically survivor
comorbidities (Boehmer et al., 2016) and caregivers’ own
reported number of comorbidities (Janz et al., 2016). One study
examined the relationship between FCR and survivor’s physical
health and found that increased caregiver FCR was associated
with poorer physical health of survivors (Kim et al., 2012).
Medical Follow-Up
One study, reported in two articles, used a three week diary
to investigate the impact of a mammogram on FCR, which
reported that there was a significant increase in FCR during days
leading up to the mammogram, and avoidance of threatening
stimuli was predictive of FCR on the day of the mammogram
(Soriano et al., 2019). However, it was not stated whether
confounding demographic variables were controlled for in this
analysis. Following the mammogram, partner responsiveness
(response perceived as genuine and enthusiastic) predicted lower
caregiver FCR, whilst patient capitalization attempts (disclosure
of positive events) predicted greater FCR at week 3 (Soriano et al.,
2018b). However, Soriano et al. (2018b) did not report a sample
size calculation, therefore findings may be at risk of Type I errors.
Psychosocial Factors
Emotional Distress
There were significant associations found between level of anxiety
and FCR. Three studies assessed the relationship between anxiety
and FCR, all of which reported a weak positive association
between anxiety and higher FCR (r =0.24 to 0.39) (Kim et al.,
2012; Soriano et al., 2018a, 2019)2. One study used the Hospital
Anxiety and Depression Scale to examine the relationship
between emotional distress (anxiety and depression combined)
and FCR and reported a strong positive association (r = 0.73)
(Hodges et al., 2009).
Interpersonal Factors
Data indicated mixed support for significant associations
between survivors’ and family caregivers’ FCR (Table 4). Nine
studies, reported in ten articles, assessed the relationship between
survivors’ and caregiver FCR. Of these, eight studies found weak
to moderate associations between survivor and family caregiver
FCR scores (r = 0.19 to 0.53) (Mellon and Northouse, 2001;
Mellon et al., 2007; Kim et al., 2012; Boehmer et al., 2016;
van de Wal et al., 2017; Soriano et al., 2018a, 2019; Perndorfer
et al., 2019), which remained significant when controlling for
other variables at 6 months post-diagnosis (Hodges et al., 2009).
However, the quality of studies that report these findings are
mixed, as six of the nine studies do not report a sample size
calculation (Mellon and Northouse, 2001; Mellon et al., 2007;
Boehmer et al., 2016; Soriano et al., 2018a, 2019; Perndorfer
et al., 2019), whereas three studies did state this calculation
(Hodges et al., 2009; Kim et al., 2012; van de Wal et al., 2017).
Consequently, it is unclear if the aforementioned studies are
sufficiently powered and are potentially at risk of Type I errors.
Two studies examined the association between relationship
quality and FCR, with one study reporting a significant positive
association which was also found in next-day FCR when
measured over 21 days (Soriano et al., 2018a). Three studies,
reported in five articles, assessed the relationship between
social support and FCR. Of these, one study found that social
support was significantly negatively associated with FCR when
controlling for other variables (Boehmer et al., 2016). One
study investigated the relationship between loneliness and FCR,
reporting a weak positive association between loneliness and FCR
(r = 0.27) (Maguire et al., 2017).
One study examined the relationship between negative affect
(assessed using the Positive and Negative Affect Schedule) and
FCR, which found that as spousal negative affect increased, so
did FCR level (Soriano et al., 2018a).
2Anxiety was assessed using the Profile of Mood States – Short Form (34), the
Hospital Anxiety and Depression Scale (27), and the PROMIS Anxiety Short Form
questionnaire (38).









































TABLE 4 | Main study findings.
Dependent
variable
Independent variables Significant findings










Sexual orientation; Co-residence; Years
since diagnosis; Treatment type; Survivor
comorbidities; Chemotherapy;
Co-residence
Caregiver use of counseling in relation to
cancer diagnosis; Social support (Survivor,
Caregiver); Experience of discrimination
(Caregiver); FCR score (Survivor)
Non-psychosocial
Years since diagnosis (β = −0.25***);
Anti-estrogen therapy (β = 0.22***);
Survivor comorbidities (β = 0.25***)
Psychosocial
Caregiver and Survivor FCR: r2 = 0.29***
Social support (Caregiver) (β = −0.24***)




Age (Patient); Religion (Patient, Partner);
Employment status (Patient, Partner);
Education level (Patient, Partner);
Self-perceived health status (Patient);
Treatment type (radiotherapy); Cancer
stage; Living arrangement (Partner)










Age (Survivors, Partners); Ethnicity;
Education; Religion; Comorbidities; Time
since diagnosis
Social constraints; Cognitive processing Non-psychosocial
Education r = −0.164*
Psychosocial
X (social constraints); M (cognitive
processing)
Indirect effect = 0.184, 95% bootstrap
CI = 0.119 to 0.271.
Direct effect = 0.038, p = 0.469, 95% CI
= −0.066 to−0.142.
[F (3,215) = 27.917, R
2 = 0.280, p < 0.001]
Dempster et al.
(2011)
CARS 13.93 (5.83) Correlations;
Regression
Age; Gender; Relationship to survivor;
Months since diagnosis; Comorbidities
Anxiety; Depression; Illness perceptions:
Acute/chronic timeline; Cyclical timeline;
Treatment control; Emotional cause;
Behavioral cause; Externalized cause;
Consequences (Patient, Carer); Personal






Age (β = −0.171***)
Psychosocial
Cyclical timeline: r = 0.275***;
Consequences (Patient): r = 0.306***;
Consequences (Carer): r = 0.475***
Reflection/relaxation: r = 0.333***;
Diversion: r = 0.327***; Interpersonal:
r = 0.354***
Illness coherence (Carer) (β = −0.093*);
Consequences (Carer) (β = 0.273***);
Externalized cause (β = −0.124**)
Reflection/relaxation (β = 0.165**); Positive









Age; Gender; Relationship to survivor;
Living arrangement; Months since
diagnosis; Other illness/medical condition
Anxiety; Depression; IPQR-Cluster 2 vs.






IPQR-Cluster 3 vs. 1 (β = −0.205*);


























































































TABLE 4 | Continued
Dependent
variable
Independent variables Significant findings










Age (Patient, Carer); Gender (Patient,
Carer); Relation to patient; Co-habiting
status; Children; Employment status;
Cancer site; Cancer stage
Anxiety; Depression; FCR score (Patient) Non-psychosocial
None.
Psychosocial
Carer FCR (3 and 6 months) r = 0.754***;
Patient and carer FCR (6 months)
r = 0.375**
Carer distress: r = 0.734**; (β = 0.20**);
Patient FCR (3 months) (β = 0.18**); Carer
FCR (3 months) (β = 0.69*)
Janz et al. (2016) Worry scaleh
N = 212 (47.1%)
Logistic regression Age; Ethnicity; Education level; Health
status; Comorbidities; Cancer stage;
Treatment type (Chemotherapy, Radiation,
Surgery)
Received enough information on risk of
recurrence from health care providers;
Emotional support from health care
providers;
Non-psychosocial
Non-Hispanic Black (β = 0.053**); Latino
(higher acculturation) (β = 3.05**); Latino
(lower acculturation) (β = 2.96**);
One or more comorbidities (β = 1.95*);
Chemotherapy (β = 2.77**)
Psychosocial
None.




Age (Survivor, Caregiver); Cancer severity Anxiety; Quality of life (QoL): mental health
and physical health (Survivor, Caregiver);
FCR score (Survivor)
Non-psychosocial
Age: r = −0.174***; Cancer severity
(β = 0.197***)
Psychosocial
QoL Mental health (Caregiver): r
= −0.296***; Anxiety: r = 0.239***;
Survivor and Caregiver FCR: r = 0.19***;
QoL Physical health (Survivor):




WOC 9.6 (5.82) Correlations;
Multiple regression
Age (Survivor, Caregiver); Gender
(Caregiver); Time since diagnosis; Cancer
stage; Treatment type (Surgery,
Chemotherapy, Radiotherapy);
Relationship to survivor; Employment
status
Financial stress of caring; Time caring;
Social support; Loneliness; QoL (Survivor)
Non-psychosocial
Time since diagnosis: r = −0.18*;
Chemotherapy: r = 0.14*; Extent of
surgery: r = −0.25***
Age (Survivor) (b = −0.22*); Age
(Caregiver) (b = 0.22*); Caregiver gender:
(r = 0.21*); (b = 0.25***); Extent of surgery
(b = −0.23***)
Psychosocial
Survivor QoL: r = −0.28***; Time caring:
r = 0.34***; Loneliness: r = 0.27***
Financial stress of caring: (b = 0.20*);



























































































TABLE 4 | Continued
Dependent
variable
Independent variables Significant findings
Author, (year) FCR score (SD) Analysis Non-psychosocial
(demographic, clinical)
Psychosocial
Mellon et al. (2006) FRQ 73.1 (14.1) Correlations None. Family stressors; Family hardiness; Social
support; Family meaning of illness; Family




Family stressors: r = 0.29*; Meaning of
illness: r = −0.28**; QoL: r = −0.29*




Age (Survivor, Caregiver); Gender (Survivor,
Caregiver); Ethnicity (Survivor, Caregiver);
Education level (Survivor, Caregiver); Role
of relationship to survivor; Time since
diagnosis; Other health problems
Concurrent family stressors (Actor effect,
Partner effect); Family hardiness; Social
support; Family meaning of cancer illness
(Actor effect, Partner effect); Somatic
concerns; FCR score (survivor)
Non-psychosocial
Age (Partner effect): (β = −0.52*)
Psychosocial
Concurrent family stressors: r = 0.29**;
Meaning of cancer illness: r = −0.28**;
Survivor FCR: r = 0.41***
Concurrent family stressors (Actor effect):
(β = 0.34***); Family meaning of cancer
illness (Actor effect): (β = −1.24**);






Correlations None. Family QoL; Family stressors; Family
hardiness; Family social support; Family





Family QoL: r = −0.33***; Family
stressors: r = 0.24**; Patient FCR:







Correlations None. Daily protective buffering (Patient,





Protective buffering (Patient): r = 0.15***;
Protective buffering (Spouse): r = 0.25***;
Evening intimacy (Patient): r = −0.12***;







Age (Patient); Patient physical symptoms Social Constraints (Patient, Spouse);
Anxiety; Depression; Relationship quality
(Patient, Spouse)
Non-psychosocial
Age (Patient) (β = −0.028*)
Psychosocial
FCR (Patient and Spouse): r = 0.53***;
Anxiety r = 0.31*; Social constraints
(Spouse): (β = 0.561*); Relationship quality


























































































TABLE 4 | Continued
Dependent
variable
Independent variables Significant findings





FCRI = 1.51 Correlations;
Modeling analysis
None Social Constraints (Patient, Spouse);
Negative affect (Patient, Spouse);
Relationship quality (Patient, Spouse); FCR




FCR score (Patient and Spouse):
r = 0.22***; Social constraints: r = 0.27**;
Negative affect: r = 0.32**
(DV: Same day FCR):
Social constraints (Spouse):
(β = 0.978***)k; Social constraints
(Patient): (β = 1.088*); Negative affect
(Spouse): (β = 0.496**)
(DV: Next day FCR):
Negative affect (Spouse): (β = 0.255**);









T3 = 0.570 (1.483)






T3: Capitalization attempt (Spouse)m
(β = 0.488**); Patient capitalization





FCRI 0.96 (1.78) Correlations;
Modeling analysis
None Threat sensitivity (Patient, Spouse); Anxiety




Patient FCR: r = 0.29*; Anxiety (Spouse):
r = 0.39*;
Threat sensitivity (Spouse): (β = 0.408**)
van de Wal et al.
(2017)
CWSo 12.6 (3.5) Regression; Mean
comparison
Age (Partner); Years a couple; Cancer
history (Partner); Education level (Partner);
Children; Time since diagnosis; Type of
treatment
FCR score (Survivor); Health-related QoL
(physical, social, physical role and
emotional role functioning; mental health;
vitality; pain; general health)
Non-psychosocial
Age: (β = −0.295*)
Psychosocial
Survivor FCR score: (r = 0.44***);
(β = 0.304***)
High partner FCR vs low partner FCR:
Emotional role functioning (p = 0.023*);
Mental health (p < 0.001***); Vitality


























































































TABLE 4 | Continued
Dependent
variable
Independent variables Significant findings
Author, (year) FCR score (SD) Analysis Non-psychosocial
(demographic, clinical)
Psychosocial
Wu et al. (2019) Cancer specific
worry measurep
NR
Modeling analysis Type of treatment (Radiation, Surgery) FCR scores at baseline and six-months
(Patient, Spouse)
Non-psychosocial
Six-month time point: Surgery (β
= −0.25**)
Psychosocial
Six-month time point: Baseline FCR
(Spouse) (β = 0.62***)
Twelve-month time point: Six-month FCR
(Spouse) (β = 0.73***)





None Illness representation; Daily Couple





Spouses’ perception of positive
information: (β = −0.168***); Spouses’
perceptions of negative information: (β
= 1.045***)
aFRQ = Fear of Cancer Recurrence Questionnaire (Northouse, 1981). Higher scores indicate greater level of FCR (score range 22 – 110).
bCaregivers of cancer survivors who identify as heterosexual women (HSW).
cCaregivers of cancer survivors who identify as sexual minority women (SMW).
dMAX-PC = Memorial Anxiety Scale for Prostate Cancer (Roth et al., 2003). Scale consists of 18 items, four-point Likert scale. Higher scores indicative of higher anxiety.
eCARS = Concerns About Recurrence Scale (Vickberg, 2003). Four items, ranging from 0 to 5. Higher scores indicative of greater FCR.
f IPQ Clusters: Cluster 1 = Carers have increasingly strong causal beliefs, particularly beliefs in emotional cause; Cluster 2 = Carers increasingly believe that they and the survivor understand condition, and feel over time that there will
be less severe consequences for themselves and the survivor; Cluster 3 = Carers report decreasing belief in severe consequences for survivor and carer, increase in perception that condition is acute and increase in all control beliefs.
gWOC = Worry Of Cancer scale (Easterling and Leventhal, 1989). Total composite score from two items used ranged from 0-20.
hAdapted worry scale used in previous publications (Janz et al., 2011, 2014). Scores M = ≥ 3 considered “worriers”.
iAdapted from Zhao et al. (2009). measure. Higher score reflects greater FCR, zero score reflects moderate levels of FCR.
jFCRI = Fear of Cancer Recurrence Inventory (Simard and Savard, 2009). Six items ranging from 0-4. Higher scores indicative of greater FCR.
kRandom effects greater but still significant.
lOne week prior to diary period.
mN = 56 couples.
nN = 53 couples.
oCWS = Cancer Worry Scale, stipulating a cut-off score for high FCR as ≥14.
pDiefenbach et al. (1999). Mean of two responses calculated, higher scores indicated greater FCR.
qFive items adapted from prior research (Thewes et al., 2012), rated on a seven-point Likert scale.
Methods: Multivariate regression models analysis (regression, mixed models and generalized linear); Modeling analysis (path analysis, structure equation modeling and actor-partner interdependence model). NR = Not Reported.
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Five studies investigated the impact of communication on
FCR, all of which found significant results. Specifically, on
a day that partners perceived the cancer survivor to be
less available or responsive to discussions of cancer-related
worries, partners were more likely to have greater FCR on
that same day, but not the next day (Soriano et al., 2018a).
One study found that patient disclosures of positive events
resulted in decreased FCR as did partner responsiveness which
was perceived to be genuine and enthusiastic (Soriano et al.,
2018b). However, it is unclear if the adapted measure used to
assess partner responsiveness is validated. Similar findings were
reported whereby partners’ perceptions of positive information
(e.g., supportive and inclusive) and negative information (e.g.,
indifferent) resulted in a change in FCR (Xu et al., 2019).
One study reported that cognitive processing mediated the
relationship between social constraints and FCR (Cohee et al.,
2017). Attempting to protect one’s partner by hiding cancer-
related concerns was weakly positively associated with increased
FCR (r = 0.15) (Perndorfer et al., 2019).
Stress and Coping
Two studies, reported in four articles, assessed the relationship
between stressors and FCR, all of which found significant
results. Specifically, care-related stressors (financial impact and
time-burden associated with caregiving) (Maguire et al., 2017)
were positively associated with FCR, whilst a weak positive
relationship was reported between stressors related to ill health
and FCR (r= 0.24 to 0.29) (Mellon and Northouse, 2001; Mellon
et al., 2006, 2007).
Two studies assessed the relationship between coping
strategies and FCR. Of these, one study reported a weak positive
association between interpersonal coping (e.g., seeking support
from cancer survivor) and FCR (r = 0.35) (Dempster et al.,
2011), whilst another study found that this association remained
significant when other variables were controlled (Graham et al.,
2016). Although the latter study indicated a 40% drop out rate
over time, there were no significant differences on depression
or FCR between participants who provided complete data and
those who provided data at one time point only (Graham et al.,
2016). One study found that increased use of reflection and
relaxation was a significant predictor of higher FCR at 12 months
follow-up, whilst those with a hopeful and in-control outlook
exhibited lower FCR (Graham et al., 2016). The authors suggested
that the association between increased use of diversionary and
relaxation coping skills and greater anxiety may be indicative of
such strategies reinforcing avoidance, which may be beneficial in
the short term but maintains anxiety in the longer term.
Quality of Life
Four studies, reported in five articles, assessed the relationship
between QoL and FCR. All studies found a significant result,
indicating a weak positive association between QoL and FCR
(r = −0.28 to 0.33) (Mellon and Northouse, 2001; Mellon et al.,
2006; Kim et al., 2012; Maguire et al., 2017). Specifically, higher
FCR was linked to lower QoL scores, including poorer caregiver
mental health (Kim et al., 2012), lower survivor QoL (Maguire
et al., 2017) and poorer family QoL (Mellon and Northouse,
2001; Mellon et al., 2006). One study found significant differences
between health-related QoL in partners with high and low FCR,
reporting that partners with high FCR obtained significantly
lower scores on social functioning, emotional role functioning,
mental health, vitality and general health (van deWal et al., 2017).
Most of the studies that reported on QoL met the key criteria
of the quality assessment and reported on relatively large sample
sizes ranging from 123 to 455.
Psychological Beliefs
One study, reported in three articles, examined the relationship
between the meaning of illness and FCR, reporting a weak
negative association between negative meaning of illness and
FCR (r = −0.27 to −0.28; (Mellon and Northouse, 2001; Mellon
et al., 2006, 2007). Three studies assessed the relationship between
illness perceptions and FCR, all of which reported significant
findings (Dempster et al., 2011; Graham et al., 2016; Xu et al.,
2019). Specifically, one study found that an understanding of
the disease was negatively associated with FCR, whilst belief
of less serious consequences and control over condition were
positively associated with FCR (Dempster et al., 2011). One study
reported that caregivers with a reduction in beliefs of severe
consequences and causes of the condition, and an increase in
control beliefs and understanding of the condition was associated
with decreased FCR over a 12-month time period (Graham et al.,
2016). One study found that over a 10 days period, spouses’
negative illness representations were negatively associated with
their own disclosures of positive information (Xu et al., 2019).
However, this study did not state a sample size calculation
therefore statistical analysis may be underpowered and at risk of
Type I error rates.
DISCUSSION
This review summarized cross-sectional and prospective
quantitative research investigating the demographics, clinical
and psychological factors associated with FCR in caregivers of
cancer survivors. Sixteen studies, reported in 19 articles, were
included and summarized narratively. Significant associations
were found between FCR and certain non-modifiable factors,
including younger age and treatment modality. Although there
was only limited research investigating psychological processes
(n = 3), significant associations were found between illness
perceptions and FCR. Specifically, a good understanding of the
cancer diagnosis was negatively associated with FCR, whilst
belief of less serious consequences and control over the condition
were positively associated with FCR.
There were mixed findings with regards to demographic
factors and level of FCR. Younger age was significantly associated
with FCR (Mellon et al., 2007; Dempster et al., 2011; Kim et al.,
2012; Janz et al., 2016;Maguire et al., 2017; van deWal et al., 2017;
Soriano et al., 2018a), which may be due to the unexpectedness of
cancer in younger age and the perceived negative physical, social
or economic impact of such a disease (Llewellyn et al., 2008; Lebel
et al., 2013). Limited significant outcomes were reported with
regards to the remaining demographic factors. Similar findings
have been reported in the cancer survivor literature, whereby
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no demographic, clinical or social factors reliably predicted
subsequent distress in cancer survivors (Cook et al., 2018).
Of the 13 studies that assessed the association between
clinical outcomes and FCR, six reported significant associations.
Specifically, time since diagnosis (Boehmer et al., 2016; Maguire
et al., 2017) was significantly associated with higher FCR, whilst
which contrasts with the cancer survivorship literature (Crist
and Grunfeld, 2013; Koch et al., 2013; Simard et al., 2013).
Four studies found that treatment modality was significantly
associated with FCR, which is consistent with the cancer
patient and survivorship literature that indicates that different
treatment approaches are significantly associated with FCR (Yang
et al., 2017a,b; Maguire et al., 2018). Patients who have had
chemotherapy or radiotherapy are likely to experience side
effects, and an increased number of hospital trips and inpatient
episodes, which may contribute to psychological morbidity
(Denlinger and Barsevick, 2009). Furthermore, research has
indicated that some patients may choose more invasive surgeries
even when the risk of recurrence is low, in order to eliminate
risk to the greatest possible extent (Williams and Jeanetta,
2016). Consequently, caregivers may perceive surgery as a more
conclusive treatment, and therefore may be of the view that
the cancer is less likely to return, as opposed to treatment side
effects and multiple hospital trips which may act as triggers
of FCR. Only one study explored the association between
clinical follow-up (mammogram) and FCR, which reported a
significant association (Soriano et al., 2019). As caregivers often
attend medical appointments with the survivor (LeSeure and
Chongkham-ang, 2015), it is likely that such follow-ups may also
act as a trigger for FCR in caregivers.
Two studies reported a significant association between
comorbidities and caregiver FCR (Boehmer et al., 2016; Janz
et al., 2016). Internal physiological cues related to comorbid
conditions may be misinterpreted as possible cancer recurrence,
thus symptoms may act as a reminder of vulnerability and
trigger FCR (Leventhal et al., 1980; Lee-Jones et al., 1997; Crist
and Grunfeld, 2013). Caregivers are likely to witness survivors
expressing somatic concerns and reporting treatment side effects,
therefore, they may be more vigilant regarding changes in the
survivors’ physical health which may exacerbate worries that
the cancer might return. Furthermore, lack of communication
between the dyad may lead to worry regarding somatic concerns
and side effects (Cohee et al., 2017; Soriano et al., 2018a).
However, similarly to demographic factors, clinical indicators are
not as critical as psychological factors in the development and
maintenance of FCR, and there are intrapersonal factors which
need to be considered.
Of the psychosocial factors examined, communication
significantly affected FCR. The less someone was able to tell
their partner about their cancer-related concerns, the more likely
they were to experience FCR (Cohee et al., 2017; Soriano et al.,
2018a). Unsupportive partner behaviors (i.e., critical or avoidant
responses) are associated with both patient and partner reports
of hiding concerns and disengagement (Manne et al., 2014). One
study reported that caregivers hiding their own cancer-related
worries in an attempt to protect the survivor was associated
with increased FCR (Perndorfer et al., 2019). Caregivers can
be reluctant to discuss emotions relating to cancer for fear of
burdening or upsetting the patient (LeSeure and Chongkham-
ang, 2015; Tolbert et al., 2018), but this may be contraindicated
as a helpful strategy.
The review findings indicated that caregivers relied on various
coping strategies, including reflection, relaxation, diversion
and interpersonal approaches (e.g., through requiring frequent
reassurance regarding FCR), which were significant predictors
of higher FCR (Dempster et al., 2011; Graham et al., 2016).
Research also highlights that caregivers engage in a high use
of avoidance, distraction and denial (Papastavrou et al., 2012;
Lambert et al., 2013), yet acknowledge that such strategies are
only temporarily effective (LeSeure and Chongkham-ang, 2015).
Consequently, it is likely that FCR is exacerbated and maintained
as the psychological distress is not explicitly addressed.
Significant outcomes were reported for psychological
processes, specifically illness perceptions (Dempster et al., 2011;
Graham et al., 2016; Xu et al., 2019). Similar findings have been
reported in the cancer survivorship, as illness perceptions have
been associated with higher FCR and worry about cancer more
generally (Corter et al., 2013; Park et al., 2013; Simard et al., 2013).
Furthermore, individual interpretations or representations are
often more influential than clinical characteristics in determining
FCR (Llewellyn et al., 2008). However, a review of psychological
distress in cancer survivors reported no consistent evidence that
illness appraisals predicted longer-term distress (Cook et al.,
2018).
This review provides preliminary evidence that theoretical
models used to understand FCR in cancer survivors may
also be applicable to caregivers. For example, the limited
research investigating psychological beliefs indicates that
illness perceptions explained additional variance in FCR when
controlling for demographic and clinical characteristics. This
provides support for the Common Sense Model (Leventhal
et al., 1980) which states that individuals create cognitive
and emotional interpretations of an illness threat, in order to
appraise and determine if the threat is serious and requires
attention. However, the limited explanatory power of the three
studies that examined illness perceptions suggest that this model
does not fully account for variance in FCR in caregivers of
cancer survivors and indicate a need to look beyond illness
perceptions. The broader blended model of FCR (Lebel et al.,
2018) argues that triggers, perceived risk of recurrence and illness
uncertainty predict FCR, whilst positive beliefs about worrying
and intolerance of uncertainty act indirectly to increase FCR
by increasing maladaptive coping. In this review, interpersonal
factors such as communication and social support, as well as type
of treatment and clinical follow-up were significantly associated
with increased FCR, therefore lending support for the utility
of this model in understanding FCR experienced by caregivers.
Furthermore, the findings of this review suggest that caregivers
implement maladaptive coping strategies such as diversion and
reassurance seeking, which were significant predictors of FCR.
Interventions that aim to reduce FCR in patients which focus on
cognitive processing and metacognitions, rather than the content
of thoughts, have been found to be more effective than traditional
cognitive behavioral approaches (Tauber et al., 2019). Given that
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similar factors are reported to exist for caregivers as survivors,
it may be that interventions based on the aforementioned
theoretical frameworks may also be applicable to caregivers.
Study Limitations and Implications for
Research
There are several limitations which must be taken into
consideration. As only published data were searched and
included in this review, there is a possibility that relevant
studies were missed. Furthermore, only citations written in
English were considered for inclusion for review, which may
have resulted in a language, selection or cultural bias. The aim
of the review was to synthesize correlates and predictors of
FCR in cancer survivors so as to produce a comprehensive
overview of the current state of evidence with regards to factors
associated with, and underpinning, FCR. As such, we only
included quantitative studies. However, inclusion of qualitative
studies may have provided valuable context or additional insights
into the findings of this review. Meta-analysis of data was not
possible to heterogeneity in included studies, which limited the
depth of analysis possible. We focused, instead, on narratively
summarizing the results of univariate and multivariate analyses,
with preference given to the most complex/controlled analyses.
However, this may make comparison with other literature
difficult, and should be considered when interpreting findings.
Various methodological limitations of the included studies
were identified. There is likely to be a risk of self-selection bias
as recruitment methods were reliant on patients responding to
the research adverts. Eight out of the 16 studies used a cross-
sectional study design, thus precluding the ability to draw causal
inferences. Only four of the prospective studies included in the
review reported an adequate follow-up period; the remainder
used experiential sampling methodology with follow-up periods
ranging from 10 days to 3 weeks. Most studies reported data
from the USA and participants were predominantly Caucasian
females, thus may not reflect a representative sample of the
population. It is also important to note that cancer patients were
in different stages of diagnosis, therefore associations with FCR
could differ as those caring for patients with more advanced
cancer may perceive the diagnosis as being more serious and
more likely to recur (Simard et al., 2013). Future research should
attempt to address the observed limitations by recruiting larger,
more representative samples of carers of patients with a range of
different cancers.
With regards to the quality of studies, only five studies
reported a sample size calculation, thus studies are potentially
statistically underpowered and at risk of Type I error rates.
Researchers should ensure that this is stipulated in future
research papers, in order to ensure confidence in the statistical
power of findings. Only three studies considered psychological
beliefs associated with FCR in family caregivers (Dempster et al.,
2011; Graham et al., 2016; Xu et al., 2019); further prospective
research in this area is warranted.
Clinical Implications
Health professionals may want to consider certain demographic
and clinical factors, such as younger age and treatment
modality, when offering information on treatment approaches
and providing the space to discuss concerns about recurrence.
Previous research has identified a need for planning for transition
from patient to “survivor” (Gilbert et al., 2008; Houlihan,
2009), which involves discussions around treatment, ongoing
management, managing FCR and identifying triggers for seeking
help and support from healthcare team (Humphris and Ozakinci,
2006). Caregivers should be involved in care planning with the
opportunity to discuss their fears about the cancer returning.
Involvement in care planning would provide the caregiver with
greater guidance on the most appropriate ways of supporting the
cancer survivor. In cases where the patient does not want the
caregiver to be involved in the care plan, caregivers should be
offered their own support as the cancer experience can result in
the caregiver adapting to a potentially altered future and sense of
self (Tolbert et al., 2018).
CONCLUSIONS
The results of the review indicate that caregiver FCR is a
significant concern and highlights the importance of furthering
current understanding of this prevalent issue. Weak to
moderate associations were found between certain demographic
and clinical factors and increased FCR. Further research
examining modifiable factors are required, in order to enhance
understanding of the psychological processes that are involved in
the development and maintenance of FCR in caregivers of cancer
survivors. By investigating modifiable factors, this will provide
evidence and guide the development of appropriate and effective
interventions for this population.
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